Dicerna Pharmaceuticals (DRNA) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Where to Rent Stable Turkish Datacenter Proxies?

July 1, 2025 Where to Rent Stable Turkish Datacenter Proxies?

In a digital landscape where online anonymity and efficiency are essential, datacenter proxies have become a fundamental tool for businesses, SEO specialists, and…
PayPal’s News Analysis—A Short and Medium-Term Price Forecast

June 24, 2025 PayPal’s News Analysis—A Short and Medium-Term Price Forecast

This analytical article cuts through the noise, offering a focused forecast for PYPL’s stock price movement in both the short (5 days) and…
Understanding Accounting and Bookkeeping Services for Business Success

June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success

Every successful business relies on accurate financial records. From managing cash flow to ensuring compliance with tax regulations, reliable accounting and bookkeeping services…
How much does a Turkish passport cost?

May 27, 2025 How much does a Turkish passport cost?

Turkish citizenship comes with numerous benefits. Once granted, a foreigner can enter 126 countries visa-free, enjoy high-quality healthcare and favorable tax regimes, and…
How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…

Dicerna Pharmaceuticals (DRNA) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: July 7, 2025 (23:07)

Sector: Healthcare

The share price of Dicerna Pharmaceuticals, Inc. (DRNA) now

This company is DELISTED
Latest session on the 28th of December for
Dicerna Pharmaceuticals, Inc. is negative
Trading Volume: 0
Open: 38.22 /  High: 38.22 /  Low: 38.22
Current value: $38.22

Are you interested in Dicerna Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Dicerna Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Dicerna Pharmaceuticals share be worth in 2025 - 2027?

When should I take profit in Dicerna Pharmaceuticals stock? When should I record a loss on Dicerna Pharmaceuticals stock? What are analysts' forecasts for Dicerna Pharmaceuticals stock? What is the future of Dicerna Pharmaceuticals stock? We forecast Dicerna Pharmaceuticals stock performance using neural networks based on historical data on Dicerna Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Dicerna Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Dicerna Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Dicerna Pharmaceuticals stock

The chart below shows the historical price of Dicerna Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Dicerna Pharmaceuticals stock price can be found in the table below.

No data

Long-term forecasts by years.

Biopharmaceutical company Dicerna Pharmaceuticals, Inc. specializes in the discovery and development of pharmaceuticals based on the interference of ribonucleic acid (RNAi). The company develops pharmaceuticals using its GalXC RNAi platform to treat liver diseases, including rare diseases, viral infections, chronic liver diseases, and cardiometabolic diseases.

Trending Themes in the Healthcare Sector

Dicerna Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 09 38.25 37.46 38.80 3.58
Jul 10 38.45 38.01 39.33 3.49
Jul 11 38.90 38.39 39.15 1.98
Jul 12 37.73 37.00 38.14 3.06
Jul 13 37.57 37.21 37.99 2.09
Jul 14 37.12 36.37 37.99 4.44
Jul 15 36.99 36.45 37.37 2.53
Jul 16 36.70 36.11 37.14 2.84
Jul 17 35.60 34.87 35.94 3.06
Jul 18 34.99 34.16 35.56 4.12
Jul 19 34.58 34.27 35.09 2.39
Jul 20 34.45 34.08 35.28 3.52
Jul 21 34.97 34.57 35.81 3.58
Jul 22 34.51 34.07 35.23 3.40
Jul 23 34.45 34.01 34.98 2.86
Jul 24 35.47 35.24 36.01 2.20
Jul 25 35.52 34.70 36.08 3.96
Jul 26 35.02 34.77 35.47 2.02
Jul 27 35.01 34.73 35.61 2.54
Jul 28 35.41 34.93 36.20 3.62
Jul 29 35.17 34.34 35.85 4.39
Jul 30 34.69 34.15 35.35 3.50
Jul 31 34.21 33.79 34.65 2.55
Aug 01 34.39 33.94 35.05 3.25
Aug 02 34.15 33.47 34.68 3.61
Aug 03 34.56 33.81 34.92 3.28
Aug 04 34.72 34.50 35.39 2.60
Aug 05 35.09 34.43 35.91 4.31
Aug 06 34.67 34.35 35.22 2.54
Aug 07 34.28 33.54 34.59 3.13

Dicerna Pharmaceuticals Daily Price Targets


Dicerna Pharmaceuticals Stock Forecast 07-09-2025.

Forecast target price for 07-09-2025: $38.25.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 3.460%.
Pessimistic target level: 37.46
Optimistic target level: 38.80

Dicerna Pharmaceuticals Stock Forecast 07-10-2025.

Forecast target price for 07-10-2025: $38.45.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 3.372%.
Pessimistic target level: 38.01
Optimistic target level: 39.33

Dicerna Pharmaceuticals Stock Forecast 07-11-2025.

Forecast target price for 07-11-2025: $38.90.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 1.937%.
Pessimistic target level: 38.39
Optimistic target level: 39.15

Dicerna Pharmaceuticals Stock Forecast 07-12-2025.

Forecast target price for 07-12-2025: $37.73.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.968%.
Pessimistic target level: 37.00
Optimistic target level: 38.14

Dicerna Pharmaceuticals Stock Forecast 07-13-2025.

Forecast target price for 07-13-2025: $37.57.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.047%.
Pessimistic target level: 37.21
Optimistic target level: 37.99

Dicerna Pharmaceuticals Stock Forecast 07-14-2025.

Forecast target price for 07-14-2025: $37.12.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 4.250%.
Pessimistic target level: 36.37
Optimistic target level: 37.99

DRNA (DRNA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jul. 41.03 37.29 43.20 13.68
Aug. 42.87 38.07 48.29 21.16
Sep. 42.94 41.22 47.13 12.54
Oct. 45.07 41.82 49.32 15.20
Nov. 41.25 38.67 44.09 12.28
Dec. 40.32 37.03 43.74 15.34

Dicerna Pharmaceuticals forecast for this year


Dicerna Pharmaceuticals Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $41.033. Pessimistic: $37.29. Optimistic: $43.20


Dicerna Pharmaceuticals Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $42.8713. Pessimistic: $38.07. Optimistic: $48.29


Dicerna Pharmaceuticals Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $42.9399. Pessimistic: $41.22. Optimistic: $47.13


Dicerna Pharmaceuticals Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $45.0697. Pessimistic: $41.82. Optimistic: $49.32


Dicerna Pharmaceuticals Stock Prediction for Nov 2025

An downtrend is forecast for this month with an optimal target price of $41.2478. Pessimistic: $38.67. Optimistic: $44.09


Dicerna Pharmaceuticals Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $40.3238. Pessimistic: $37.03. Optimistic: $43.74



Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 38.13 36.06 40.63 11.26
Feb 38.01 34.60 41.35 16.32
Mar 38.07 34.78 41.97 17.13
Apr 35.08 31.15 36.66 15.01
May 30.26 26.92 31.76 15.24
Jun 32.10 28.40 34.66 18.07
Jul 35.33 31.66 37.37 15.28
Aug 37.37 33.78 39.52 14.52
Sep 36.59 32.37 39.05 17.09
Oct 36.41 34.55 39.15 11.76
Nov 37.99 34.95 39.20 10.85
Dec 41.88 38.93 43.42 10.34

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 44.69 39.33 47.05 16.41
Feb 47.55 42.30 53.26 20.57
Mar 47.17 42.79 50.34 14.99
Apr 43.85 38.94 46.03 15.40
May 37.04 34.97 39.00 10.33
Jun 39.65 34.58 42.13 17.92
Jul 44.16 42.53 47.83 11.08
Aug 41.40 38.62 45.71 15.51
Sep 42.99 40.45 46.98 13.91
Oct 38.80 34.26 40.35 15.08
Nov 41.65 37.59 44.45 15.44
Dec 40.12 38.51 43.71 11.89

Dicerna Pharmaceuticals information and performance

Dicerna Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization of the Dicerna Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DRNA shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Dicerna Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Dicerna Pharmaceuticals Stock)

Should I Buy Dicerna Pharmaceuticals Shares in 2025 year?

The maximum forecasted share price for next year is $41.88, which is $3.66 higher than the current stock price. By investing in Dicerna Pharmaceuticals shares today for a one-year period, you could achieve a profit of 9.57%. With an investment horizon of up to two years, the target share price is $47.55. resulting in a profit of 24.41% ($9.33 per share).

Does Dicerna Pharmaceuticals pay dividends?

No, it does not

Which economic sector do Dicerna Pharmaceuticals's shares belong to?

Dicerna Pharmaceuticals's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Dicerna Pharmaceuticals's shares?

You can view all the stocks that are part of the same sector as Dicerna Pharmaceuticals's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.